References
- Demetri G D, Griffin J D. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–2808
- Bronchud M H, Potter M R, Morgenstern G. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer 1988; 58: 64–69
- Gabrilove J L, Jakubowski A, Fain K. A phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest. 1988; 82: 1454–1461
- Morstyn G, Souza L M, Keech J. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–671
- Jakubowski A, Souza L, Kelly F. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med. 1989; 320: 38–42
- Hammond W P, Price T H, Souza L M, Dale D C. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med. 1989; 320: 1306–1311
- Glaspy J A, Baldwin G C, Robertson P A. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med. 1988; 109: 789–795
- Welte K, Zeidler C, Reiter A. Differential effects of granulocyte-macrophage colony-stimulating factor in children with sever congenital neutropenia. Blood 1990; 75: 1056–1063
- McCluskey R T, Fineberg R. Vasculitis in primary vasculitides, granulomatoses, and connective tissue diseases. Hum Pathol. 1983; 14: 305–315